Navigation Links
Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
Date:4/28/2008

ncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable gene based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in the company's' Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
2. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
3. Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference
4. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
6. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
7. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
8. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
9. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
10. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
11. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
(Date:11/24/2009)...NMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neurog...ocusedondevelopingandcommercializingnovelpainmanag...esidentandChiefExecutiveOfficer,isscheduledtoprese...tobeheldDecember1-2,2009atTheNewYorkPalaceHotelinN...i,ChiefFinancialOfficer,willbeavailabletorespondto...
(Date:11/24/2009)... The FBI recently approved the Prom... participating in or generating DNA records for th... Madison, WI USA (PRWEB) -- The FBI recently ... for use by laboratories participating in, or gene...tem (NDIS). NDIS currently contains more than seve...
(Date:11/24/2009)...BLIN,November24/PRNewswire-FirstCall/--Shireplc(LS...ceuticalcompany,today,announcedthatithassubmitteda...fa,thecompany,senzymereplacementtherapyindevelopme...hirdmarketing,applicationforvelaglucerasealfathath...dStatesandCanada. , Basedonaglobalsupplyshort...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...-Ever United Nations World Diabetes Day, Experts P...n of UN Resolution on Diabetes, NEW YORK, Nov. 14...nagement today called for an overhaul in the world... and prevention in order to reverse,the rising dia...ited,Nations (UN) World Diabetes Day. In a new pub...
...Nov. 14 Techne Corporation,(Nasdaq: TECH ) today...zed,the repurchase of up to $150 million of the Co...rchase authorization does not have an expiration d...Company spends and the number,of shares it ultimat...ent,and will depend on factors such as current sto...
..., and TORONTO, Nov. 13 /PRNewswire/ - BioRelix, pi...tch based therapeutic agents and,Dalton Medicinal ...boration,to discover new therapeutics. Dalton Med...sights to,design and synthesize several novel clas...ts. BioRelix will advance these compounds using th...
Other Biology Technology:International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 2International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 3International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact 4Techne Corporation Announces Share Repurchase Authorization 2BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2
(Date:11/24/2009)... ROUGE Antarctica has long held secrets of the ea...recently, there has been very little information o...iles of ice for millions of years. Now, a team of ... have been funded to the tune of $10 million dolla...get to the bottom of things literally. These scie...
(Date:11/23/2009)...ATINew research presents strong evidence that the ...h outdoor traffic-related pollution and indoor end...ne or the other exposure alone. , Environmenta...i (UC) College of Medicine have shown that childre...articles and indoor endotoxin during early life ar...
(Date:11/23/2009)... study by the Wildlife Conservation Society says t...mp in the Republic of Congopart of the "mother lod...earare becoming increasingly threatened by growing...mmends protection of the swamp forests adjacent to...after recent surveys confirmed that high densities...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2California American Water Celebrates No Drugs Down the Drain Week in San Diego 6041 1California American Water Celebrates No Drugs Down the Drain Week in San Diego 6041 2A New Era of E Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 60815 1A New Era of E Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 60815 2SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 1SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 2SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 3SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 4SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 5
...st dangerous form of malaria is difficult to treat...hers at Karolinska Institutet in Sweden have devel... Severe anaemia, respiratory problems and encephal...s of serious malaria infection. The diseases are c...cts the red blood cells, which then accumulate in ...
... can be exposed to methamphetamine or "crystal met...samples, published ahead of print in the Fetal and...ood. , Unlike hair, the most commonly used detect...g term use, nor can they always distinguish among ...aightening the hair will not erase the chemical ev...
...the causes of autism remain complex and mysterious...tricate puzzle. In what they believe to be a signi...rum disorders" (ASD), researchers have developed a... brain hypertrophy characteristic of the disease. ...arada and his colleagues report the results of rem...
Other Biology News:Hair samples show babies can be exposed to 'crystal meth' while in the womb 2Mutant mice show key autism traits 2
Capped Xef-1 RNA 0.05 ml from Ambion
Human TIMP-1 ELISpot Kit from R&D Systems
Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Human sVCAM-1 / CD106 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Biology Products: